Discontinued — last reported Q3 '24
Welltower Outpatient Medical — D&A decreased by 0.4% to $66.50M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 0.9%, from $65.92M to $66.50M. Over 2 years (FY 2021 to FY 2023), Outpatient Medical — D&A shows an upward trend with a 8.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher values relative to revenue may suggest an aging portfolio or significant intangible asset base requiring replacement.
The non-cash expense allocated to the Outpatient Medical segment to account for the gradual wear and tear of physical pr...
Standard across all real estate and capital-intensive industries as a component of operating expenses.
well_segment_outpatient_medical_depreciation_and_amortization| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $55.44M | $56.35M | $56.33M | $57.79M | $59.56M | $60.38M | $61.96M | $64.18M | $66.28M | $65.92M | $66.92M | $66.53M | $66.75M | $66.50M |
| QoQ Change | — | +1.6% | -0.0% | +2.6% | +3.1% | +1.4% | +2.6% | +3.6% | +3.3% | -0.5% | +1.5% | -0.6% | +0.3% | -0.4% |
| YoY Change | — | — | — | — | +7.4% | +7.1% | +10.0% | +11.1% | +11.3% | +9.2% | +8.0% | +3.7% | +0.7% | +0.9% |